DK1140861T3 - Hidtil ukendte polyhydroxypyrazinforbindelser, deres fremstilling samt farmaceutiske præparater indeholdende disse forbindelser - Google Patents

Hidtil ukendte polyhydroxypyrazinforbindelser, deres fremstilling samt farmaceutiske præparater indeholdende disse forbindelser

Info

Publication number
DK1140861T3
DK1140861T3 DK00900538T DK00900538T DK1140861T3 DK 1140861 T3 DK1140861 T3 DK 1140861T3 DK 00900538 T DK00900538 T DK 00900538T DK 00900538 T DK00900538 T DK 00900538T DK 1140861 T3 DK1140861 T3 DK 1140861T3
Authority
DK
Denmark
Prior art keywords
compounds
choh
cor
preparation
polyhydroxypyrazine
Prior art date
Application number
DK00900538T
Other languages
Danish (da)
English (en)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1140861T3 publication Critical patent/DK1140861T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00900538T 1999-01-11 2000-01-07 Hidtil ukendte polyhydroxypyrazinforbindelser, deres fremstilling samt farmaceutiske præparater indeholdende disse forbindelser DK1140861T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900186A FR2788274B1 (fr) 1999-01-11 1999-01-11 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2000/000026 WO2000042027A1 (fr) 1999-01-11 2000-01-07 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1140861T3 true DK1140861T3 (da) 2003-10-20

Family

ID=9540746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900538T DK1140861T3 (da) 1999-01-11 2000-01-07 Hidtil ukendte polyhydroxypyrazinforbindelser, deres fremstilling samt farmaceutiske præparater indeholdende disse forbindelser

Country Status (24)

Country Link
US (1) US6818637B2 (pt)
EP (1) EP1140861B1 (pt)
JP (1) JP4516694B2 (pt)
KR (1) KR100648324B1 (pt)
CN (1) CN1145615C (pt)
AT (1) ATE244226T1 (pt)
AU (1) AU774627B2 (pt)
BR (1) BR0007449B1 (pt)
CA (1) CA2359463C (pt)
CZ (1) CZ301380B6 (pt)
DE (1) DE60003631T2 (pt)
DK (1) DK1140861T3 (pt)
EA (1) EA003550B1 (pt)
ES (1) ES2198273T3 (pt)
FR (1) FR2788274B1 (pt)
HU (1) HU228761B1 (pt)
IL (2) IL143945A0 (pt)
NO (1) NO320398B1 (pt)
NZ (1) NZ512911A (pt)
PL (1) PL200682B1 (pt)
PT (1) PT1140861E (pt)
SK (1) SK286389B6 (pt)
WO (1) WO2000042027A1 (pt)
ZA (1) ZA200105657B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425596C (zh) * 2006-03-29 2008-10-15 中国烟草总公司郑州烟草研究院 脱氧果糖嗪的制备方法
CN101697972B (zh) * 2009-11-16 2011-08-10 朱峰 新曲霉酸在制备抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238081A1 (en) * 1995-11-22 1997-05-29 S. Jane Desolms Inhibitors of farnesyl-protein transferase
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments
FR2766185B1 (fr) * 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation

Also Published As

Publication number Publication date
EA003550B1 (ru) 2003-06-26
FR2788274A1 (fr) 2000-07-13
NO20013416D0 (no) 2001-07-10
SK9762001A3 (en) 2001-12-03
CA2359463C (fr) 2009-09-15
EP1140861A1 (fr) 2001-10-10
CN1352638A (zh) 2002-06-05
NO20013416L (no) 2001-09-06
FR2788274B1 (fr) 2001-02-09
SK286389B6 (sk) 2008-09-05
IL143945A (en) 2006-04-10
JP2002534513A (ja) 2002-10-15
JP4516694B2 (ja) 2010-08-04
NZ512911A (en) 2003-10-31
HU228761B1 (en) 2013-05-28
CZ20012483A3 (cs) 2001-10-17
KR100648324B1 (ko) 2006-11-23
PT1140861E (pt) 2003-11-28
DE60003631T2 (de) 2004-06-03
US6818637B2 (en) 2004-11-16
EP1140861B1 (fr) 2003-07-02
HUP0105104A3 (en) 2002-09-30
WO2000042027A1 (fr) 2000-07-20
ES2198273T3 (es) 2004-02-01
EA200100767A1 (ru) 2001-12-24
IL143945A0 (en) 2002-04-21
KR20010101456A (ko) 2001-11-14
PL200682B1 (pl) 2009-01-30
PL348768A1 (en) 2002-06-03
CA2359463A1 (fr) 2000-07-20
BR0007449A (pt) 2001-10-16
DE60003631D1 (de) 2003-08-07
CN1145615C (zh) 2004-04-14
HUP0105104A2 (hu) 2002-07-29
AU774627B2 (en) 2004-07-01
BR0007449B1 (pt) 2011-08-09
ZA200105657B (en) 2002-10-10
NO320398B1 (no) 2005-11-28
AU3051500A (en) 2000-08-01
US20020077324A1 (en) 2002-06-20
CZ301380B6 (cs) 2010-02-03
ATE244226T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
ATE180257T1 (de) Pyrazolderivate
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
MX9605721A (es) Boratos estables al acido para fotopolimerizacion.
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
DK0635499T3 (da) Nye acaricidt aktive tetrazinderivater
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
AR036000A1 (es) Proceso para la preparacion de derivados de indol y novedosos intermediarios
TW200624541A (en) Flameproof rubber-reinforced styrenic resin composition
DK1140861T3 (da) Hidtil ukendte polyhydroxypyrazinforbindelser, deres fremstilling samt farmaceutiske præparater indeholdende disse forbindelser
BRPI9707889B8 (pt) composto e seus sais, composição farmacêutica, utilização do composto.
BR0001744A (pt) Processo para a preparação de 2-alquila-3-aminotiofeno útil como um fungicida agrìcola ou seu intermediário
AU5840686A (en) Improvements in or relating to pyrazoles
AU576926B2 (en) Tetrazole derivatives
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
ATE93861T1 (de) Synthese von beta-lactamverbindungen.
GB917078A (en) Improvements in or relating to piperidine derivatives
ES2173901T3 (es) Composiciones farmaceuticas que contienen derivados de isoquinolina
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
DK0998464T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
GB938646A (en) New piperazine derivatives
TH2445A (th) ไพริมิดีนที่ถูกแทนที่
NO20010244L (no) Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene
GB822517A (en) N-substituted-4-phenyl-4-carboxylic piperidines and the preparation thereof
DE69610150T2 (de) Neue fungizide Verbindungen LL-15G256g, d und e, hergestellt von LL-15G256(Hypoxylon oceanicum)